ENTPD1 and Stroke: Pinsky et al. showed that CD39 knockout mice exhibited increased cerebral infarct volumes, and decreased post ischemic perfusion, and exogenous addition of soluble recombinant CD39 was able to reduce thrombosis, increase post-ischemic perfusion, and decrease cerebral infarct volumes in vivo even when given 3 h post-stroke.